Market Price

0.84 

0.01 1.0%

as of Jul 18 '19

52 Week Range:

0.60 0.87


Stock Analyzer Tutorials

S2O Stock Analyzer - General Info

General Info


type: video (mp4); length: 3:30

Demonstrates how to use Stock Analyzer, shows how to analyze a stock and explains in detail "General Info" section of the Stock Analyzer result page.

S2O Stock Analyzer - Financial Statements

Financial Statements


type: video (mp4); length: 5:10

Explains information presented in the Financial Statements section of the S2O Stock Analyzer: financial statements charts, absolute values and growth rates.

S2O Stock Analyzer - Growth Grade and Financial Ratios

Growth Grade and Financial Ratios


type: video (mp4); length: 5:09

Demonstrates how to use Growth Grade & Financial Ratios section; shows the difference between historical and year-over-year Growth Grade on the real life example.

S2O Stock Analyzer - Value Price

Value Price


type: video (mp4); length: 6:03

Demonstrates how to use Value Price (intrinsic value) and the Graham Number, MOS (margin of safety) and IRT - Investment Recovery Time; explains 3 different projection models used to compute value price - pessimistic, moderate and optimistic.

S2O Stock Analyzer - Price Charts

Price Charts


type: video (mp4); length: 8:34

Demonstrates basic rules of how to read a candlestick chart, long and short term moving averages, stochastic, MACD and relative strength (RS) charts. Explains how bull or bear market condition is computed.

General Info

Shandong Weigao Group Medical Polymer Company Limited engages in the research and development, production, and sale of single-use medical devices in the People's Republic of China. The company operates through Medical Device Products, Orthopaedic Products, Interventional Products, Pharma Packaging Products, Blood Management Products, and Others segments. It offers vascular and non-vascular access infusion devices, including infusion sets, syringes, puncture needles, and specialized single-use clinical collection kits; wound healing dressings, wound sutures, and wound cleaning and nonvascular catheter supporting extracorporeal devices; and blood collection, storage, separation, and sterilization equipment. The company also provides prefilled syringes and pre-filled flush syringes; blood collection and blood glucose testing devices; and general anesthesia consumables, local anesthesia consumables, anesthesia auxiliary consumables, ICU equipment, and open and minimally invasive surgical equipment. In addition, it engages in the production and sale of orthopedic products; tumor and blood vessel interventional instruments; implantation materials and artificial organs; medical PVC granules, plastic packing bags, and carton boxes; industrial automatic equipment and parts; molds; hemo-dialysis equipment; and type I, type II, and type III medical devices. Further, the company is involved in the finance leasing and factoring business; wholesale of type I medical devices, surgical devices, and other disposal medical products; and provision of asset management and enterprise consulting services, as well as logistics and storage services. Shandong Weigao Group Medical Polymer Company Limited offers its products under the Jierui, Wego Ortho, Yahua, Bangde, and Hai Xing brands. The company also export its products. It serves hospitals, blood stations, and other medical units; and distributors. The company was founded in 2000 and is based in Weihai, the People's Republic of China.

Financial Statements

The charts below show selected Annual and Quarterly Financial Data.

The purpose of these charts is to discover long and short term change dynamics. When numbers are growing year after year in the annual statements chart, the business become stronger and stronger and this is a good sign.

Quarterly Data Chart can be used to do a short term analysis. It makes sense to pay attention to the quarterly dynamics and do not wait for the next yearly statement. We should be alerted if we see that quarterly numbers are going down.

You can check "Annual Financial Statements" and "Quarterly Financial Statements" sections for exact numbers and growth rates.

Annual Statements

On a charts below the Line shows absolute values and the Bar chart shows Year-Over-Year Growth Rate for selected financial statement item. A consistent GROWTH is generally considered necessary to fund future growth from within a business.
NOTE: Growth Rate is not provided if either the latest period or the year-ago period contains a net loss. (source: WSJ Digest of Earnings)
TIP! move your mouse pointer over bar or a circle on any chart below to see details.

Financial Statements

Income Statement



 

Cash Flow Statement



 

Balance Sheet



 

Liquidity Ratios

Current Ratio


 

Current Ratio measures the ability to meet short term obligations. Generally accepted standard is 2 (current assets should be 2 times or 200% of current liabilities).

Quick Ratio


 

Measures immediate liquidity or the cash available to cover immediate liabilities. A safe margin would be at least 1 (100%).

Financial Leverage


 

Defined as total assets divided by total shareholders' equity. The higher the ratio, the more debt a company uses in its capital structure.

Profitability Ratios

ROA


 

Return on Assets (ROA) measures the income (profit) that is generated by the use of the assets of the business.

ROE


 

Return on Equity (ROE) is a measure of profitability that calculates how many dollars of profit a company generates with each dollar of shareholders equity. ROE is sometimes called "return on net worth."

ROIC


 

The Return on Invested Capital (ROIC) measure gives a sense of how well a company is using its money to generate returns. Some investors use this figure as a final evaluation to determine whether or not to invest in a company.

Annual Statements

Item Name Dec '08 Dec '09 Dec '10 Dec '11 Dec '12 Dec '13 Dec '14 Dec '15 Dec '16 Dec '17 Dec '18
Equity (BVPS) 0.03
0.06
0.08
0.14
0.23
0.25
0.28
0.32
0.34
0.35
0.39
growth rate 100.0% 33.3% 75.0% 64.3% 8.7% 12.0% 14.3% 6.3% 2.9% 11.4%
Earnings BIT 1,064.93
1,124.42
1,284.59
1,106.00
1,373.65
1,823.47
growth rate 5.6% 14.2% -13.9% 24.2% 32.8%
Avg.PE 19.50
18.06
8.20
14.76
growth rate -7.4% -54.6% 80.0%
ROA 17.60
17.38
18.58
49.38
10.04
3.56
9.29
8.70
7.56
10.63
7.23
growth rate -1.3% 6.9% 165.8% -79.7% -64.5% 161.0% -6.4% -13.1% 40.6% -32.0%
ROE 25.36
23.41
24.34
58.54
11.65
4.32
11.49
10.85
9.82
13.73
10.58
growth rate -7.7% 4.0% 140.5% -80.1% -62.9% 166.0% -5.6% -9.5% 39.8% -22.9%
ROIC 23.84
22.15
23.65
57.59
11.47
4.22
10.83
9.98
9.02
12.32
9.18
growth rate -7.1% 6.8% 143.5% -80.1% -63.2% 156.6% -7.9% -9.6% 36.6% -25.5%
Cur. Ratio 2.78
2.31
2.42
3.58
2.53
3.00
3.39
3.78
3.23
3.94
3.22
growth rate -16.9% 4.8% 47.9% -29.3% 18.6% 13.0% 11.5% -14.6% 22.0% -18.3%
Quick Ratio 2.35
1.82
2.00
3.05
1.84
2.47
2.79
3.27
2.78
3.41
2.71
growth rate -22.6% 9.9% 52.5% -39.7% 34.2% 13.0% 17.2% -15.0% 22.7% -20.5%
Leverage 1.35
1.34
1.28
1.14
1.18
1.25
1.23
1.27
1.33
1.26
1.65
growth rate -0.7% -4.5% -10.9% 3.5% 5.9% -1.6% 3.3% 4.7% -5.3% 31.0%
Balance Sheet Dec '08 Dec '09 Dec '10 Dec '11 Dec '12 Dec '13 Dec '14 Dec '15 Dec '16 Dec '17 Dec '18
Acct.Receivable 1,531.00
2,122.43
2,801.83
2,814.39
3,555.72
4,235.22
5,041.45
growth rate 38.6% 32.0% 0.5% 26.3% 19.1% 19.0%
Acct.Payable 922.00
990.26
674.54
478.65
594.15
651.77
946.07
growth rate 7.4% -31.9% -29.0% 24.1% 9.7% 45.2%
Cur.Assets 3,871.00
6,253.42
6,799.04
7,526.28
8,682.27
9,054.19
10,717.53
growth rate 61.6% 8.7% 10.7% 15.4% 4.3% 18.4%
Total Assets 10,479.00
11,288.10
12,070.11
13,519.25
15,756.31
16,781.02
23,986.87
growth rate 7.7% 6.9% 12.0% 16.6% 6.5% 42.9%
Cash 1,298.00
2,975.62
2,786.09
3,712.15
4,071.89
3,784.55
3,812.45
growth rate 129.3% -6.4% 33.2% 9.7% -7.1% 0.7%
Inventory 830.00
866.36
914.52
850.59
915.59
805.56
1,137.31
growth rate 4.4% 5.6% -7.0% 7.6% -12.0% 41.2%
Cur.Liabilities 1,530.00
2,082.30
2,002.93
2,001.64
2,683.92
2,303.46
3,326.73
growth rate 36.1% -3.8% -0.1% 34.1% -14.2% 44.4%
Liabilities 1,558.00
2,225.16
2,190.52
2,732.42
3,551.05
3,142.57
8,795.97
growth rate 42.8% -1.6% 24.7% 30.0% -11.5% 179.9%
LT Debt 99.70
149.10
649.20
791.80
804.27
5,092.89
growth rate 49.6% 335.4% 22.0% 1.6% 533.2%
Equity 9,040.35
9,847.91
10,658.18
11,866.58
13,334.51
14,514.57
growth rate 8.9% 8.2% 11.3% 12.4% 8.9%
Common Shares 3,994.00
8,610.00
4,305.00
4,418.00
4,476.00
4,476.00
4,476.00
4,478.00
4,478.00
4,483.00
4,484.00
growth rate 115.6% -50.0% 2.6% 1.3% 0.0% 0.0% 0.0% 0.0% 0.1% 0.0%
Cash Flow Statement Dec '08 Dec '09 Dec '10 Dec '11 Dec '12 Dec '13 Dec '14 Dec '15 Dec '16 Dec '17 Dec '18
Capital Expenditures 924.00
948.86
731.72
1,113.51
619.67
1,428.81
794.79
growth rate 2.7% -22.9% 52.2% -44.4% 130.6% -44.4%
Cash Dividends 277.54
277.54
331.25
252.52
490.56
217.90
growth rate 0.0% 19.4% -23.8% 94.3% -55.6%
Cash From OA 806.00
720.17
711.22
1,052.77
1,053.14
1,265.86
2,219.20
growth rate -10.7% -1.2% 48.0% 0.0% 20.2% 75.3%
FCF per Share 0.01
-0.01
-0.01
-0.01
0.02
0.01
growth rate -100.0% 0.0% 0.0% 100.0% -50.0%
FCF 235.00
161.00
184.00
-515.00
-218.00
-294.00
-39.00
-78.00
414.00
-246.00
1,424.00
growth rate -31.5% 14.3% -100.0% 0.0% 0.0% 0.0% 0.0% 100.0% -100.0% 100.0%
Income Statement Dec '08 Dec '09 Dec '10 Dec '11 Dec '12 Dec '13 Dec '14 Dec '15 Dec '16 Dec '17 Dec '18
Sales 3,689.00
4,613.31
5,277.83
5,918.93
5,619.84
6,292.64
8,808.86
growth rate 25.1% 14.4% 12.2% -5.1% 12.0% 40.0%
Op.Income 996.00
1,064.93
1,124.42
1,284.59
1,106.00
1,373.65
1,823.47
growth rate 6.9% 5.6% 14.2% -13.9% 24.2% 32.8%
IBT 544.15
1,275.66
1,335.51
1,186.68
1,525.61
1,775.22
growth rate 134.4% 4.7% -11.1% 28.6% 16.4%
Net Income 996.00
387.98
1,084.95
1,112.74
1,105.93
1,728.66
1,472.94
growth rate -61.1% 179.6% 2.6% -0.6% 56.3% -14.8%
EPS 0.12
0.07
0.19
0.78
0.22
0.09
0.24
0.25
0.25
0.39
0.33
growth rate -41.7% 171.4% 310.5% -71.8% -59.1% 166.7% 4.2% 0.0% 56.0% -15.4%
Gross Profit 2,112.00
2,726.87
3,104.31
3,515.56
3,577.75
3,991.11
5,502.44
growth rate 29.1% 13.8% 13.3% 1.8% 11.6% 37.9%
R&D 208.92
238.10
292.66
266.04
273.83
311.16
growth rate 14.0% 22.9% -9.1% 2.9% 13.6%

Quarterly Statements

Item Name Dec '17 Mar '18 Jun '18 Sep '18 Dec '18
Earnings BIT 452.97
452.97
458.77
458.77
growth rate 0.0% 1.3% 0.0%
Balance Sheet Dec '17 Mar '18 Jun '18 Sep '18 Dec '18
Acct.Receivable 4,239.53
4,581.25
4,581.25
5,041.45
5,041.45
growth rate 8.1% 0.0% 10.1% 0.0%
Acct.Payable 651.77
853.55
853.55
946.07
946.07
growth rate 31.0% 0.0% 10.8% 0.0%
Cur.Assets 9,056.12
9,109.13
9,109.13
10,717.53
10,717.53
growth rate 0.6% 0.0% 17.7% 0.0%
Total Assets 16,782.86
22,598.06
22,598.06
23,986.87
23,986.87
growth rate 34.7% 0.0% 6.2% 0.0%
Cash 3,784.54
2,964.23
2,964.23
3,812.45
3,812.45
growth rate -21.7% 0.0% 28.6% 0.0%
Inventory 804.61
1,009.94
1,009.94
1,137.31
1,137.31
growth rate 25.5% 0.0% 12.6% 0.0%
Cur.Liabilities 2,299.65
3,151.04
3,151.04
3,326.73
3,326.73
growth rate 37.0% 0.0% 5.6% 0.0%
Liabilities 3,138.75
8,146.59
8,146.59
8,795.97
8,795.97
growth rate 159.6% 0.0% 8.0% 0.0%
LT Debt 804.27
4,636.04
4,636.04
5,092.89
5,092.89
growth rate 476.4% 0.0% 9.9% 0.0%
Equity 13,338.17
13,839.10
13,839.10
14,514.57
14,514.57
growth rate 3.8% 0.0% 4.9% 0.0%
Common Shares 452.23
452.23
452.23
452.23
452.23
growth rate 0.0% 0.0% 0.0% 0.0%
Cash Flow Statement Dec '17 Mar '18 Jun '18 Sep '18 Dec '18
Capital Expenditures 397.40
397.40
397.40
397.40
growth rate 0.0% 0.0% 0.0%
Cash Dividends 102.96
102.96
102.96
6.00
6.00
growth rate 0.0% 0.0% -94.2% 0.0%
Cash From OA 480.10
480.10
480.10
629.49
629.49
growth rate 0.0% 0.0% 31.1% 0.0%
FCF 82.71
82.71
232.10
232.10
growth rate 0.0% 180.6% 0.0%
Income Statement Dec '17 Mar '18 Jun '18 Sep '18 Dec '18
Sales 2,075.25
2,075.25
2,329.18
2,329.18
growth rate 0.0% 12.2% 0.0%
Op.Income 452.97
452.97
452.97
458.77
458.77
growth rate 0.0% 0.0% 1.3% 0.0%
IBT 386.10
386.10
386.10
501.51
501.51
growth rate 0.0% 0.0% 29.9% 0.0%
Net Income 325.03
325.03
411.44
411.44
growth rate 0.0% 26.6% 0.0%
Gross Profit 1,306.52
1,306.52
1,444.70
1,444.70
growth rate 0.0% 10.6% 0.0%
R&D 70.85
70.85
70.85
84.73
84.73
growth rate 0.0% 0.0% 19.6% 0.0%

Growth Grade & Financial Ratios

All financial ratios below are calculated based on latest annual statements available and present the most up to date snapshot of a company finances.

Growth Grade

Historical Growth Grade:

A (84.19)

YOY Growth Grade:

C (51.04)

Click on buttons above for detailed yearly growth rates.

Market Ratios

Profitability Ratios

Liquidity Ratios

Efficiency Ratios

Value Price

PE and EPS

Historical Current Forward
PE 13.90 14.24
EPS / Growth 0.06

Value Price & Investment Recovery Time

Read more about Stock2Own value price in Stock Market: Fundamental Analysis.

Equity Growth Rate: 10.1%

Estimates Pessimistic Moderate Optimistic My Numbers
Rate of Return 15.0%
MOS Price % 50 %
Future EPS Growth 10.1% 10.1% 10.1%
Future PE 0.01 11.36 11.36
Future EPS 0.15 0.15 0.15
Value Price
MOS %
0.00
-100.0%
0.43
-48.5%
0.43
-48.5%
MOS Price 0.00 0.22 0.22
IRT 8.68 8.68 8.68

Graham Number:

NOTE: The Graham Number applies only to certain types of stocks in combination with a number of other criteria.

Read more about Graham Number in Stock Market: Fundamental Analysis.

Price Chart

The functionality you are trying to reach is available to registered users only.

Login to your account or Register Now if you are not registered yet. Registration is FREE and will take only a minute.

Risk / Reward Ratios

The functionality you are trying to reach is available to registered users only.

Login to your account or Register Now if you are not registered yet. Registration is FREE and will take only a minute.